Endocrine-Related Cancer

References

1. ↵
   1. Aghi M &
   2. Barker FG

   2006 Benign adult brain tumors: an evidence-based medicine review. Progress in Neurological Surgery 19 80–96.
2. ↵
   1. Allan CA,
   2. Kaltsas G,
   3. Evanson J,
   4. Geddes J,
   5. Lowe DG,
   6. Plowman PN &
   7. Grossman AB

   2001 Pituitary chondrosarcoma: an unusual cause of a sellar mass presenting as a pituitary adenoma. Journal of Clinical Endocrinology and Metabolism 86 386–391.
3. ↵
   1. Allen JC

   1987 Management of primary intracranial germ cell tumors of childhood. Pediatric Neuroscience 13 152–157.
4. ↵
   1. Allen JC,
   2. Kim JH &
   3. Packer RJ

   1987 Neoadjuvant chemotherapy for newly diagnosed germ-cell tumors of the central nervous system. Journal of Neurosurgery 67 65–70.
5. ↵
   1. Arceci RJ

   1999 The histiocytoses: the fall of the Tower of Babel. European Journal of Cancer 35 747–767.
6. ↵
   1. Arico M,
   2. Girschikofsky M,
   3. Genereau T,
   4. Klersy C,
   5. McClain K,
   6. Grois N,
   7. Emile JF,
   8. Lukina E,
   9. De Juli E &
   10. Danesino C

   2003 Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. European Journal of Cancer 39 2341–2348.
7. ↵
   1. Balmaceda C,
   2. Heller G,
   3. Rosenblum M,
   4. Diez B,
   5. Villablanca JG,
   6. Kellie S,
   7. Maher P,
   8. Vlamis V,
   9. Walker RW,
   10. Leibel S
   11. et al.

   1996 Chemotherapy without irradiation – a novel approach for newly diagnosed CNS germ cell tumors: results of an international cooperative trial. The First International Central Nervous System Germ Cell Tumor Study. Journal of Clinical Oncology 14 2908–2915.
8. ↵
   1. Baskin DS &
   2. Wilson CB

   1986 Surgical management of craniopharyngiomas. A review of 74 cases. Journal of Neurosurgery 65 22–27.
9. ↵
   1. Black KL &
   2. Pikul BK

   1999 Gliomas-past, present, and future. Clinical Neurosurgery 45 160–163.
10. ↵
    1. Boardman JF,
    2. Rothfus WE &
    3. Dulai HS

    2008 Lesions and pseudolesions of the cavernous sinus and petrous apex. Otolaryngologic Clinics of North America 41 195–213.
11. ↵
    1. Boari N,
    2. Losa M,
    3. Mortini P,
    4. Snider S,
    5. Terreni MR &
    6. Giovanelli M

    2006 Intrasellar paraganglioma: a case report and review of the literature. Acta Neurochirurgica 148 1311–1314.
12. ↵
    1. Brada M &
    2. Cruickshank G

    1999 Radiosurgery for brain tumours. BMJ 318 411–412.
13. ↵
    1. Bruna J,
    2. Brell M,
    3. Ferrer I,
    4. Gimenez-Bonafe P &
    5. Tortosa A

    2007 Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma. Neuropathology 27 114–120.
14. ↵
    1. Buhring U,
    2. Herrlinger U,
    3. Krings T,
    4. Thiex R,
    5. Weller M &
    6. Kuker W

    2001 MRI features of primary central nervous system lymphomas at presentation. Neurology 57 393–396.
15. ↵
    1. Bunin GR,
    2. Surawicz TS,
    3. Witman PA,
    4. Preston-Martin S,
    5. Davis F &
    6. Bruner JM

    1998 The descriptive epidemiology of craniopharyngioma. Journal of Neurosurgery 89 547–551.
16. ↵
    1. Calaminus G,
    2. Bamberg M,
    3. Harms D,
    4. Jurgens H,
    5. Kortmann RD,
    6. Sorensen N,
    7. Wiestler OD &
    8. Gobel U

    2005 AFP/beta-HCG secreting CNS germ cell tumors: long-term outcome with respect to initial symptoms and primary tumor resection. Results of the cooperative trial MAKEI 89. Neuropediatrics 36 71–77.
17. ↵
    1. Chiang MF,
    2. Brock M &
    3. Patt S

    1990 Pituitary metastases. Neurochirurgia 33 127–131.
18. ↵
    1. Chong BW &
    2. Newton TH

    1993 Hypothalamic and pituitary pathology. Radiologic Clinics of North America 31 1147–1153.
19. ↵
    1. Cohen-Gadol AA,
    2. Pichelmann MA,
    3. Link MJ,
    4. Scheithauer BW,
    5. Krecke KN,
    6. Young WF Jr.,
    7. Hardy J &
    8. Giannini C

    2003 Granular cell tumor of the sellar and suprasellar region: clinicopathologic study of 11 cases and literature review. Mayo Clinic Proceedings 78 567–573.
20. ↵
    1. Coke CC,
    2. Corn BW,
    3. Werner-Wasik M,
    4. Xie Y &
    5. Curran WJ Jr.

    1998 Atypical and malignant meningiomas: an outcome report of seventeen cases. Journal of Neuro-Oncology 39 65–70.
21. ↵
    1. Cone L,
    2. Srinivasan M &
    3. Romanul FC

    1990 Granular cell tumor (choristoma) of the neurohypophysis: two cases and a review of the literature. American Journal of Neuroradiology 11 403–406.
22. ↵
    1. Corn BW,
    2. Dolinskas C,
    3. Scott C,
    4. Donahue B,
    5. Schultz C,
    6. Nelson DF &
    7. Fisher B

    2000 Strong correlation between imaging response and survival among patients with primary central nervous system lymphoma: a secondary analysis of RTOG studies 83-15 and 88-06. International Journal of Radiation Oncology, Biology, Physics 47 299–303.
23. ↵
    1. Couldwell WT,
    2. Weiss MH,
    3. Rabb C,
    4. Liu JK,
    5. Apfelbaum RI &
    6. Fukushima T

    2004 Variations on the standard transsphenoidal approach to the sellar region, with emphasis on the extended approaches and parasellar approaches: surgical experience in 105 cases. Neurosurgery 55 539–547.
24. ↵
    1. Day JD

    2003 Surgical approaches to suprasellar and parasellar tumors. Neurosurgery Clinics of North America 14 109–122.
25. ↵
    1. Fine HA &
    2. Mayer RJ

    1993 Primary central nervous system lymphoma. Annals of Internal Medicine 119 1093–1104.
26. ↵
    1. FitzPatrick M,
    2. Tartaglino LM,
    3. Hollander MD,
    4. Zimmerman RA &
    5. Flanders AE

    1999 Imaging of sellar and parasellar pathology. Radiologic Clinics of North America 37 101–121.
27. ↵
    1. Freda PU &
    2. Post KD

    1999 Differential diagnosis of sellar masses. Endocrinology and Metabolism Clinics of North America 28 81–117.
28. ↵
    1. Freda PU,
    2. Wardlaw SL &
    3. Post KD

    1996 Unusual causes of sellar/parasellar masses in a large transsphenoidal surgical series. Journal of Clinical Endocrinology and Metabolism 81 3455–3459.
29. ↵
    1. Freeman JL,
    2. Coleman LT,
    3. Wellard RM,
    4. Kean MJ,
    5. Rosenfeld JV,
    6. Jackson GD,
    7. Berkovic SF &
    8. Harvey AS

    2004 MR imaging and spectroscopic study of epileptogenic hypothalamic hamartomas: analysis of 72 cases. American Journal of Neuroradiology 25 450–462.
30. ↵
    1. Frighetto L,
    2. De Salles AA,
    3. Behnke E,
    4. Smith ZA &
    5. Chute D

    2003 Image-guided frameless stereotactic biopsy sampling of parasellar lesions. Technical note. Journal of Neurosurgery 98 920–925.
31. ↵
    1. Giller CA &
    2. Berger BD

    2005 New frontiers in radiosurgery for the brain and body. Proceedings 18 311–319.
32. ↵
    1. Giller CA,
    2. Berger BD,
    3. Pistenmaa DA,
    4. Sklar F,
    5. Weprin B,
    6. Shapiro K,
    7. Winick N,
    8. Mulne AF,
    9. Delp JL,
    10. Gilio JP
    11. et al.

    2005 Robotically guided radiosurgery for children. Pediatric Blood & Cancer 45 304–310.
33. ↵
    1. Glezer A,
    2. Paraiba DB &
    3. Bronstein MD

    2008 Rare sellar lesions. Endocrinology and Metabolism Clinics of North America 37 195–211.
34. ↵
    1. Gobel U,
    2. Schneider DT,
    3. Calaminus G,
    4. Jurgens H,
    5. Spaar HJ,
    6. Sternschulte W,
    7. Waag K &
    8. Harms D

    2001 Multimodal treatment of malignant sacrococcygeal germ cell tumors: a prospective analysis of 66 patients of the German cooperative protocols MAKEI 83/86 and 89. Journal of Clinical Oncology 19 1943–1950.
35. ↵
    1. Guillamo JS,
    2. Doz F &
    3. Delattre JY

    2001 Brain stem gliomas. Current Opinion in Neurology 14 711–715.
36. ↵
    1. Hald JK,
    2. Eldevik OP,
    3. Brunberg JA &
    4. Chandler WF

    1994 Craniopharyngiomas – the utility of contrast medium enhancement for MR imaging at 1.5 T. Acta Radiologica 35 520–525.
37. ↵
    1. Hartmann C,
    2. Bostrom J &
    3. Simon M

    2006 Diagnostic and molecular pathology of meningiomas. Expert Review of Neurotherapeutics 6 1671–1683.
38. ↵
    1. Hoang-Xuan K,
    2. Capelle L,
    3. Kujas M,
    4. Taillibert S,
    5. Duffau H,
    6. Lejeune J,
    7. Polivka M,
    8. Criniere E,
    9. Marie Y,
    10. Mokhtari K
    11. et al.

    2004 Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. Journal of Clinical Oncology 22 3133–3138.
39. ↵
    1. Honegger J,
    2. Buchfelder M,
    3. Fahlbusch R,
    4. Daubler B &
    5. Dorr HG

    1992 Transsphenoidal microsurgery for craniopharyngioma. Surgical Neurology 37 189–196.
40. ↵
    1. Ito I,
    2. Ishida T,
    3. Hashimoto T,
    4. Arita M,
    5. Osawa M,
    6. Yokota T &
    7. Ishimori T

    2001 Hypopituitarism due to pituitary metastasis of lung cancer: case of a 21-year-old man. Internal Medicine 40 414–417.
41. ↵
    1. Jagannathan J,
    2. Kanter AS,
    3. Sheehan JP,
    4. Jane JA Jr. &
    5. Laws ER Jr.

    2007 Benign brain tumors: sellar/parasellar tumors. Neurologic Clinics 25 1231–1249.
42. ↵
    1. Jalali R,
    2. Srinivas C,
    3. Nadkarni TD &
    4. Rajasekharan P

    2008 Suprasellar haemangiopericytoma – challenges in diagnosis and treatment. Acta Neurochirurgica 150 67–71.
43. ↵
    1. Janmohamed S,
    2. Grossman AB,
    3. Metcalfe K,
    4. Lowe DG,
    5. Wood DF,
    6. Chew SL,
    7. Monson JP,
    8. Besser GM &
    9. Plowman PN

    2002 Suprasellar germ cell tumours: specific problems and the evolution of optimal management with a combined chemoradiotherapy regimen. Clinical Endocrinology 57 487–500.
44. ↵
    1. Jennings MT,
    2. Gelman R &
    3. Hochberg F

    1985 Intracranial germ-cell tumors: natural history and pathogenesis. Journal of Neurosurgery 63 155–167.
45. ↵
    1. Judge DM,
    2. Kulin HE,
    3. Page R,
    4. Santen R &
    5. Trapukdi S

    1977 Hypothalamic hamartoma: a source of luteinizing-hormone-releasing factor in precocious puberty. New England Journal of Medicine 296 7–10.
46. ↵
    1. Kaltsas GA,
    2. Powles TB,
    3. Evanson J,
    4. Plowman PN,
    5. Drinkwater JE,
    6. Jenkins PJ,
    7. Monson JP,
    8. Besser GM &
    9. Grossman AB

    2000 Hypothalamo-pituitary abnormalities in adult patients with Langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. Journal of Clinical Endocrinology and Metabolism 85 1370–1376.
47. ↵
    1. Karavitaki N,
    2. Cudlip S,
    3. Adams CB &
    4. Wass JA

    2006 Craniopharyngiomas. Endocrine Reviews 27 371–397.
48. ↵
    1. Karim M,
    2. Sylvia A,
    3. Fred G &
    4. Patrick S

    2006 Ependymoma of the pituitary fossa. Case report and review of the literature. Journal of Neurosurgery 105 616–620.
49. ↵
    1. Kitange GJ,
    2. Templeton KL &
    3. Jenkins RB

    2003 Recent advances in the molecular genetics of primary gliomas. Current Opinion in Oncology 15 197–203.
50. ↵
    1. Kleihues P,
    2. Burger PC &
    3. Scheithauer BW

    1993 The new WHO classification of brain tumours. Brain Pathology 3 255–268.
51. ↵
    1. Ko KW,
    2. Nam DH,
    3. Kong DS,
    4. Lee JI,
    5. Park K &
    6. Kim JH

    2007 Relationship between malignant subtypes of meningioma and clinical outcome. Journal of Clinical Neuroscience 14 747–753.
52. ↵
    1. Komninos J,
    2. Vlassopoulou V,
    3. Protopapa D,
    4. Korfias S,
    5. Kontogeorgos G,
    6. Sakas DE &
    7. Thalassinos NC

    2004 Tumors metastatic to the pituitary gland: case report and literature review. Journal of Clinical Endocrinology and Metabolism 89 574–580.
53. ↵
    1. Korten AG,
    2. ter Berg HJ,
    3. Spincemaille GH,
    4. van der Laan RT &
    5. Van de Wel AM

    1998 Intracranial chondrosarcoma: review of the literature and report of 15 cases. Journal of Neurology, Neurosurgery, and Psychiatry 65 88–92.
54. ↵
    1. Kunanandam V &
    2. Gooding MR

    1995 Parasellar chondrosarcoma: total excision improves prognosis. British Journal of Neurosurgery 9 87–91.
55. ↵
    1. Laigle-Donadey F,
    2. Taillibert S,
    3. Martin-Duverneuil N,
    4. Hildebrand J &
    5. Delattre JY

    2005 Skull-base metastases. Journal of Neuro-Oncology 75 63–69.
56. ↵
    1. Lamberts SW,
    2. de Herder WW &
    3. van der Lely AJ

    1998 Pituitary insufficiency. Lancet 352 127–134.
57. ↵
    1. Lefranc F,
    2. Chevalier C,
    3. Vinchon M,
    4. Dhellemmes P,
    5. Schuring MP,
    6. Kaltner H,
    7. Brotchi J,
    8. Ruchoux MM,
    9. Gabius HJ,
    10. Salmon I
    11. et al.

    2003 Characterization of the levels of expression of retinoic acid receptors, galectin-3, macrophage migration inhibiting factor, and p53 in 51 adamantinomatous craniopharyngiomas. Journal of Neurosurgery 98 145–153.
58. ↵
    1. Legido A,
    2. Packer RJ,
    3. Sutton LN,
    4. D'Angio G,
    5. Rorke LB,
    6. Bruce DA &
    7. Schut L

    1989 Suprasellar germinomas in childhood. A re appraisal. Cancer 63 340–344.
59. ↵
    1. Liu JK,
    2. Sayama C,
    3. Chin SS &
    4. Couldwell WT

    2007 Extranodal NK/T-cell lymphoma presenting as a pituitary mass. Case report and review of the literature. Journal of Neurosurgery 107 660–665.
60. ↵
    1. Louis DN,
    2. Ohgaki H,
    3. Wiestler OD,
    4. Cavenee WK,
    5. Burger PC,
    6. Jouvet A,
    7. Scheithauer BW &
    8. Kleihues P

    2007 The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica 114 97–109.
61. ↵
    1. Maira G,
    2. Anile C,
    3. Rossi GF &
    4. Colosimo C

    1995 Surgical treatment of craniopharyngiomas: an evaluation of the transsphenoidal and pterional approaches. Neurosurgery 36 715–724.
62. ↵
    1. Makras P,
    2. Alexandraki KI,
    3. Chrousos GP,
    4. Grossman AB &
    5. Kaltsas GA

    2007 Endocrine manifestations in Langerhans cell histiocytosis. Trends in Endocrinology and Metabolism 18 252–257.
63. ↵
    1. Matsutani M,
    2. Sano K,
    3. Takakura K,
    4. Fujimaki T,
    5. Nakamura O,
    6. Funata N &
    7. Seto T

    1997 Primary intracranial germ cell tumors: a clinical analysis of 153 histologically verified cases. Journal of Neurosurgery 86 446–455.
64. ↵
    1. Matthay KK,
    2. Brisse H,
    3. Couanet D,
    4. Couturier J,
    5. Benard J,
    6. Mosseri V,
    7. Edeline V,
    8. Lumbroso J,
    9. Valteau-Couanet D &
    10. Michon J

    2003 Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients. Cancer 98 155–165.
65. ↵
    1. Megan Ogilvie C,
    2. Payne S,
    3. Evanson J,
    4. Lister TA &
    5. Grossman AB

    2005 Lymphoma metastasizing to the pituitary: an unusual presentation of a treatable disease. Pituitary 8 139–146.
66. ↵
    1. Mena H,
    2. Ribas JL,
    3. Pezeshkpour GH,
    4. Cowan DN &
    5. Parisi JE

    1991 Hemangiopericytoma of the central nervous system: a review of 94 cases. Human Pathology 22 84–91.
67. ↵
    1. Meyers SP,
    2. Hirsch WL Jr.,
    3. Curtin HD,
    4. Barnes L,
    5. Sekhar LN &
    6. Sen C

    1992 Chondrosarcomas of the skull base: MR imaging features. Radiologica 184 103–108.
68. ↵
    1. Morita A,
    2. Meyer FB &
    3. Laws ER Jr.

    1998 Symptomatic pituitary metastases. Journal of Neurosurgery 89 69–73.
69. ↵
    1. Mukherjee JJ,
    2. Islam N,
    3. Kaltsas G,
    4. Lowe DG,
    5. Charlsworth M,
    6. Afshar F,
    7. Trainer PJ,
    8. Monson JP,
    9. Besser GM &
    10. Grossman AB

    1997 Clinical, radiological and pathological features of patients with Rathke's cleft cysts: tumors that may recur. Journal of Clinical Endocrinology and Metabolism 82 2357–2362.
70. ↵
    1. Nakane Y,
    2. Natsume A,
    3. Wakabayashi T,
    4. Oi S,
    5. Ito M,
    6. Inao S,
    7. Saito K &
    8. Yoshida J

    2007 Malignant transformation-related genes in meningiomas: allelic loss on 1p36 and methylation status of p73 and RASSF1A. Journal of Neurosurgery 107 398–404.
71. ↵
    1. Nelson GA,
    2. Bastian FO,
    3. Schlitt M &
    4. White RL

    1988 Malignant transformation in craniopharyngioma. Neurosurgery 22 427–429.
72. ↵
    1. Ohba S,
    2. Yoshida K,
    3. Hirose Y,
    4. Ikeda E &
    5. Kawase T

    2008 A supratentorial primitive neuroectodermal tumor in an adult: a case report and review of the literature. Journal of Neuro-Oncology 86 217–224.
73. ↵
    1. Osuka S,
    2. Tsuboi K,
    3. Takano S,
    4. Ishikawa E,
    5. Matsushita A,
    6. Tokuuye K,
    7. Akine Y &
    8. Matsumura A

    2007 Long-term outcome of patients with intracranial germinoma. Journal of Neuro-Oncology 83 71–79.
74. ↵
    1. Packer RJ

    2000 Chemotherapy: low-grade gliomas of the hypothalamus and thalamus. Pediatric Neurosurgery 32 259–263.
75. ↵
    1. Packer RJ,
    2. Cohen BH &
    3. Cooney K

    2000 Intracranial germ cell tumors. Oncologist 5 312–320.
76. ↵
    1. Perks JR,
    2. Jalali R,
    3. Cosgrove VP,
    4. Adams EJ,
    5. Shepherd SF,
    6. Warrington AP &
    7. Brada M

    1999 Optimization of stereotactically-guided conformal treatment planning of sellar and parasellar tumors, based on normal brain dose volume histograms. International Journal of Radiation Oncology, Biology, Physics 45 507–513.
77. ↵
    1. Petito CK,
    2. DeGirolami U &
    3. Earle KM

    1976 Craniopharyngiomas: a clinical and pathological review. Cancer 37 1944–1952.
78. ↵
    1. Pusey E,
    2. Kortman KE,
    3. Flannigan BD,
    4. Tsuruda J &
    5. Bradley WG

    1987 MR of craniopharyngiomas: tumor delineation and characterization. American Journal of Roentgenology 149 383–388.
79. ↵
    1. Rajan B,
    2. Ashley S,
    3. Thomas DG,
    4. Marsh H,
    5. Britton J &
    6. Brada M

    1997 Craniopharyngioma: improving outcome by early recognition and treatment of acute complications. International Journal of Radiation Oncology, Biology, Physics 37 517–521.
80. ↵
    1. Recinos PF,
    2. Sciubba DM &
    3. Jallo GI

    2007 Brainstem tumors: where are we today? Pediatric Neurosurgery 43 192–201.
81. ↵
    1. Rennert J &
    2. Doerfler A

    2007 Imaging of sellar and parasellar lesions. Clinical Neurology and Neurosurgery 109 111–124.
82. ↵
    1. La Rocca RV,
    2. Morgan KW,
    3. Paris K &
    4. Baeker TR

    1999 Recurrent chondrosarcoma of the cranial base: a durable response to ifosfamide–doxorubicin chemotherapy. Journal of Neuro-Oncology 41 281–283.
83. ↵
    1. Rosenberg AE,
    2. Brown GA,
    3. Bhan AK &
    4. Lee JM

    1994 Chondroid chordoma – a variant of chordoma. A morphologic and immunohistochemical study. American Journal of Clinical Pathology 101 36–41.
84. ↵
    1. Ruelle A,
    2. Palladino M &
    3. Andrioli GC

    1992 Pituitary metastases as presenting lesions of malignancy. Journal of Neurosurgical Sciences 36 51–54.
85. ↵
    1. Ruscalleda J

    2005 Imaging of parasellar lesions. European Radiology 15 549–559.
86. ↵
    1. Salisbury JR &
    2. Isaacson PG

    1986 Distinguishing chordoma from chondrosarcoma by immunohistochemical techniques. Journal of Pathology 148 251–252.
87. ↵
    1. Samandouras G,
    2. Kerr RS &
    3. Milford CA

    2005 Minimally invasive biopsy of parasellar lesions: safety and clinical applications of the endoscopic, transnasal approach. British Journal of Neurosurgery 19 338–344.
88. ↵
    1. Sioutos P,
    2. Yen V &
    3. Arbit E

    1996 Pituitary gland metastases. Annals of Surgical Oncology 3 94–99.
89. ↵
    1. Smith JK

    2005 Parasellar tumors: suprasellar and cavernous sinuses. Topics in Magnetic Resonance Imaging 16 307–315.
90. ↵
    1. Steel TR,
    2. Dailey AT,
    3. Born D,
    4. Berger MS &
    5. Mayberg MR

    1993 Paragangliomas of the sellar region: report of two cases. Neurosurgery 32 844–847.
91. ↵
    1. Stout AP &
    2. Murray MR

    1942 Hemangiopericytoma: a vascular tumour featuring Zimmermann's pericytes. Annals of Surgery 116 26–33.
92. ↵
    1. Suh JH &
    2. Gupta N

    2006 Role of radiation therapy and radiosurgery in the management of craniopharyngiomas. Neurosurgery Clinics of North America 17 143–148.
93. ↵
    1. Tarbell NJ,
    2. Barnes P,
    3. Scott RM,
    4. Goumnerova L,
    5. Pomeroy SL,
    6. Black PM,
    7. Sallan SE,
    8. Billett A,
    9. LaVally B,
    10. Helmus A
    11. et al.

    Advances in radiation therapy for craniopharyngiomasPediatric Neurosurgery 21 Supplement 1 1994 101–107.
94. ↵
    1. Tomlinson JW,
    2. Holden N,
    3. Hills RK,
    4. Wheatley K,
    5. Clayton RN,
    6. Bates AS,
    7. Sheppard MC &
    8. Stewart PM

    2001 Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357 425–431.
95. ↵
    1. Vidal S,
    2. Kovacs K,
    3. Lloyd RV,
    4. Meyer FB &
    5. Scheithauer BW

    2002 Angiogenesis in patients with craniopharyngiomas: correlation with treatment and outcome. Cancer 94 738–745.
96. ↵
    1. Yokota M,
    2. Tani E,
    3. Maeda Y,
    4. Morimura T,
    5. Kakudo K &
    6. Uematsu K

    1985 Acromegaly associated with suprasellar and pulmonary hemangiopericytomas. Case report. Journal of Neurosurgery 62 767–771.
97. ↵
    1. Young SC,
    2. Grossman RI,
    3. Goldberg HI,
    4. Spagnoli MV,
    5. Hackney DB,
    6. Zimmerman RA &
    7. Bilaniuk LT

    1988 MR of vascular encasement in parasellar masses: comparison with angiography and CT. American Journal of Neuroradiology 9 35–38.
98. ↵
    1. Zee CS,
    2. Go JL,
    3. Kim PE,
    4. Mitchell D &
    5. Ahmadi J

    2003 Imaging of the pituitary and parasellar region. Neurosurgery Clinics of North America 14 55–80.
99. ↵
    1. Zhang YQ,
    2. Wang CC &
    3. Ma ZY

    2002 Pediatric craniopharyngiomas: clinicomorphological study of 189 cases. Pediatric Neurosurgery 36 80–84.